Our publications related to cancer biomarkers
DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer. Oncotarget. 8(44):77207-77218.
.
2017. DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer. Oncotarget. 8(44):77207-77218.
.
2017. DUSP4 is associated with increased resistance against anti-HER2 therapy in breast cancer. Oncotarget. 8(44):77207-77218.
.
2017. Dynamic classification using case-specific training cohorts outperforms static gene expression signatures in breast cancer.. Int J Cancer. 136(9):2091-8.
.
2015. Evaluation of microarray preprocessing algorithms based on concordance with RT-PCR in clinical samples. PLoS One. 4:e5645.
.
2009. A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer.. Breast Cancer Res Treat. 140(2):219-32.
.
2013. miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients. Breast Cancer Res Treat. 160(3):446.
.
2016.